RMD 1.05% $37.39 resmed inc

News: Resmed wins patent dispute

  1. lightbulb Created with Sketch. 1
    .


    ResMed Inc (ASX:RMD) has won a patent infringement dispute over sleep disorder breathing devices, against Taiwanese manufacturer Apex Medical Corp.


     


    The US International Trade Commission will stop the importation and sale of the Apex products in the US as a result of the US government investigation started at the request of Resmed.


     


    Resmed says it’s not surprised by the swift ruling.


     


    It says it will continue to defend its patents against any future threats.


     


    Resmed generated a net profit of $143.7 million in the first half of fiscal 2013.

 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.39
Change
0.390(1.05%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.30 $37.39 $37.07 $9.449M 253.3K

Buyers (Bids)

No. Vol. Price($)
1 44 $37.32
 

Sellers (Offers)

Price($) Vol. No.
$37.39 2573 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.